跳至主要内容
临床试验/NCT00119041
NCT00119041已完成不适用

Diabetes Telemedicine Consultation: A Systems Improvement Intervention

US Department of Veterans Affairs2 个研究点 分布在 1 个国家目标入组 304 人开始时间: 2005年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
304
试验地点
2
主要终点
A1c

研究概览

简要总结

This study seeks to evaluate and document the processes of outreach consultation through joint-clinics via teleconferencing as an intervention for system improvement in care delivery and management of diabetes mellitus (DM) at a Community Based Outpatient Center (CBOCs).

详细描述

Background:

Diabetes is a national problem that has reached epidemic proportions, according to the U.S. Centers for Disease Control and Prevention. Diabetes has particular importance for the Department of Veterans Affairs (VA) because the prevalence among VA patients -- one in six, or 16 percent -- is substantially higher than in the general population.

Objectives:

The objective of this study was to evaluate and document the processes of outreach consultation through the use of joint-clinics via teleconferencing as an intervention for system improvement in care delivery and management of diabetes at CBOCs. The intervention consisted of a teleconferenced joint-clinic consultation session involving the patient, Diabetes Specialist Team, the Primary Care Provider (PCP) and other relevant care team members. The impact of the 16-month intervention was assessed based on patients who were involved in the telemedicine clinic and those who were referred to a specialist to be seen on-site at the Cleveland VAMC.

Methods:

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Current prescription of insulin or an oral hypoglycemic agent
  • •A1c > 7.0%
  • •fasting glucose levels > 130 mg/dl
  • •referred to see a consultant and are seen during the active intervention phase. Patients with either Type I or Type II DM will be included
  • •A Primary Care Provider for a Cleveland CBOC

排除标准

  • •primary care obtained at more than one site (based on stop codes with evidence of more than 1 CBOC involved in care during the last 6 months)
  • •documented dementia, aphasia, and psychosis

研究组 & 干预措施

Telemedicine CBOC

Experimental

Designated CBOC's were involved in the intervention phase where their Diabetes Mellitus (DM) patients were asked to participate in a telemedicine visit.

The Behavioral: The Diabetes Treatment Satisfaction Questionnaire given during this phase along with the Behavioral: Diabetes Empowerment Scale and the Behavioral: CBOC's undergo half-day joint-clinics via teleconference.

干预措施: The Diabetes Treatment Satisfaction Questionnaire (Behavioral)

Telemedicine CBOC

Experimental

Designated CBOC's were involved in the intervention phase where their Diabetes Mellitus (DM) patients were asked to participate in a telemedicine visit.

The Behavioral: The Diabetes Treatment Satisfaction Questionnaire given during this phase along with the Behavioral: Diabetes Empowerment Scale and the Behavioral: CBOC's undergo half-day joint-clinics via teleconference.

干预措施: Diabetes Empowerment Scale (Behavioral)

Telemedicine CBOC

Experimental

Designated CBOC's were involved in the intervention phase where their Diabetes Mellitus (DM) patients were asked to participate in a telemedicine visit.

The Behavioral: The Diabetes Treatment Satisfaction Questionnaire given during this phase along with the Behavioral: Diabetes Empowerment Scale and the Behavioral: CBOC's undergo half-day joint-clinics via teleconference.

干预措施: CBOC's undergo half-day joint-clinics via teleconference (Behavioral)

Control CBOC

No Intervention

The CBOC's not involved in the intervention phase had their patients not be involved in the telemedicine visit, but traditional education.

Provider Interviews

No Intervention

Qualitative interviews with providers

结局指标

主要结局

A1c

时间窗: baseline and 18 months

Hemoglobin A1c is a measure of glycemic control

次要结局

  • Patient Satisfaction(Base line and at18 months.)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验